Tiziana Life Science – a British biotech company – has recently bought a biobank containing DNA samples from 13,000 genealogically linked residents of Ogliastra for €258,000. What sparked the interest of the UK firm was the fact that the small village in Sardinia hosts a proportion of centenarians that is almost 50 times the one in the UK or the US.
"A study on a homogeneous and well-characterized population could advance the understanding of ageing and disease", Napoleone Ferrara (Tiziana's chairman) declared during an interview with the British newspaper The Guardian. In particular, Ogliastra presented a remarkably higher life expectancy compared to other locations in Sardinia.
Fonte: This is Italy
